CNKI《中国期刊全文数据库》收录期刊
《中国核心期刊(遴选)数据库》收录期刊
《中文科技期刊数据库》收录期刊

Progress in biosynthesis of chiral ketoprofen

Expand
  • 1.College of Biotechnology and Bioengineering,Zhejiang University of Technology,Hangzhou 310014,China;
    2.Hangzhou Anow Microfiltration Co.,Ltd.,Hangzhou 311404,China

Abstract

Ketoprofen is one of the most prominent non-steroidal anti-inflammatory drugs,which    was widely used in rheumatism,rheumatoid arthritis,myelitis,gout and other diseases.Most of
the commercially available ketoprofen drugs are racemic.However,the (S)-
enantiomer has    therapeutic activity against inflammation and pain,while the existence of(R)-    enantiomer resulted    in increased physiological side effects and toxicity.Chiral ketoprofen is currently produced by
chemical synthesis.Compared to chemical methods,biosynthesis of ketoprofen is preferable   because of its mild reaction conditions and eco-friendliness.In this review,the progress in    biosynthesis of chiral ketoprofen with lipase,esterase,and nitrile hydratase/amidase bienzyme   system as biocatalysts was summarized.

Cite this article

HU Qiwei,ZHANG Junwei,WANG Yuanshan . Progress in biosynthesis of chiral ketoprofen[J]. Bulletin of Fermentation Science and Technology, 2017 , 46(3) : 153 -157 . DOI: 10.16774/j.cnki.issn.1674-2214.2017.03.006

Outlines

/